Preventing Cervical Cancer in the 21st Century

The January session of Grand Rounds “Preventing Cervical Cancer in the 21st Century,” was viewed in 7 foreign countries and in 47 states, plus the District of Columbia.

Each year more than 4,000 U.S. women die from cervical cancer, the 4^th most common cancer in women worldwide. Over 90% of cases of cervical cancer are associated with human papillomavirus (HPV) and the risk of cancer varies among the different HPV strains. Fortunately, cervical cancer can be prevented through HPV vaccination and screening, which include Papanicolaou (Pap) and HPV DNA tests. These tests detect abnormal cells before they become cancerous (pre-cancers). If cancer develops, treatment can start early, when it is most effective.

In fact, the combination of screening and HPV vaccination could prevent up to 93% of cervical cancers. Still, gaps remain. Women at the highest risk are often not screened and HPV vaccination rates among U.S. adolescents remain low.

Please watch this session of Public Health Grand Rounds to learn about advances in screening and vaccination efforts and what can be done by communities across the country.

Beyond the Data - Preventing Cervical Cancer in the 21st Century

Each year more than 4,000 U.S. women die from cervical cancer, the fourth most common cancer in women worldwide. Fortunately, cervical cancer can be prevented through HPV vaccination and screening. In this session of “Beyond the Data,” Dr. Phoebe Thorpe and Dr. Francisco Garcia discuss successes of community-based cervical cancer prevention.